Document is current
Any future updates will be listed below
-
Authors
Hagino, Hiroshi
Jackson, Micah
Gitlin, Matthew
Wessler, Zachary
-
Funding
Funding for this research was provided by:
Amgen
- License Information
-
More Information
Article History
Received: 6 May 2021
Accepted: 28 September 2021
First Online: 12 October 2021
Declarations
:
: MG and MJ are employees of BluePath solutions which has received funding from Amgen for this project. ZW is an employee of Amgen and owns stock in Amgen. HH has received lecture fees or grants outside the submitted work from Amgen Inc., Asahi Kasei Pharma Corp., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan Co., Ltd., Mitsubishi Tanabe Pharma Corp., Mochida Pharma Corp., Ono Pharmaceutical Co., Ltd., Pfizer Japan Inc., Taisho Pharmaceutical Co., Ltd., Teijin Pharma Co., Ltd., and UCB Japan.
